4.8 Article

Nuclear Glycogenolysis Modulates Histone Acetylation in Human Non-Small Cell Lung Cancers

期刊

CELL METABOLISM
卷 30, 期 5, 页码 903-+

出版社

CELL PRESS
DOI: 10.1016/j.cmet.2019.08.014

关键词

-

资金

  1. National Institute of Health (NIH) [R01 N070899, P01 NS097197]
  2. American Cancer Society [16-182-28]
  3. NCI [K22 CA201036, R01 CA237643]
  4. American Association for Cancer Research Innovation and Discovery Grant
  5. AHA Great Rivers Affiliate Postdoctoral fellowship [12POST12030381]
  6. University of Kentucky Markey Cancer Center
  7. NIH National Center for Advancing Translational Sciences [UL1TR001998]
  8. NIH [P20 GM121327]
  9. Biospecimen Procurement & Translational Pathology Shared Resource Facility of the University of Kentucky Markey Cancer Center [P30CA177558]
  10. [133123-RSG-19-081-01-TBG]

向作者/读者索取更多资源

Nuclear glycogen was first documented in the early 1940s, but its role in cellular physiology remained elusive. In this study, we utilized pure nuclei preparations and stable isotope tracers to define the origin and metabolic fate of nuclear glycogen. Herein, we describe a key function for nuclear glycogen in epigenetic regulation through compartmentalized pyruvate production and histone acetylation. This pathway is altered in human non-small cell lung cancers, as surgical specimens accumulate glycogen in the nucleus. We demonstrate that the decreased abundance of malin, an E3 ubiquitin ligase, impaired nuclear glycogenolysis by preventing the nuclear translocation of glycogen phosphorylase and causing nuclear glycogen accumulation. Re-introduction of malin in lung cancer cells restored nuclear glycogenolysis, increased histone acetylation, and decreased growth of cancer cells transplanted into mice. This study uncovers a previously unknown role for glycogen metabolism in the nucleus and elucidates another mechanismby which cellular metabolites control epigenetic regulation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据